Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Oncrasin-1
Cat. No.:
OB0225LY-0074
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Oncrasin-1 is a small molecule compound specifically designed to target specific biomarkers of cancer cells to inhibit their growth.
Synonym:
75629-57-1; 1-(4-Chlorobenzyl)-1H-indole-3-carbaldehyde; Oncrasin 1; 1-[(4-chlorophenyl)methyl]indole-3-carbaldehyde; 1-[(4-Chlorophenyl)methyl]-H-indole-3-carboxaldehyde; 1-[(4-Chlorophenyl)methyl]-1H-indole-3-carbaldehyde
CAS No.:
75629-57-1
Compound CID:
872445
Formula:
C16H12ClNO
Formula Weight:
269.73
Specification
Relative Density:
1.21 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Oncrasin-1 can be used as a potent anticancer inhibitor to kill various human lung cancer cells harboring K-Ras mutations.
Library Information
Targets:
GTPase superfamily
Receptors:
K-Ras
Pathways:
MAPK; Apoptosis; GPCR/G protein
Plate Number:
AOCL-1
Plate Location:
h7
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
43 mg/mL; 159.42 mM
